文献速递中毒与环境急症心脑血管急症

碳酸氢钠治疗安非他酮过量所致QRS增宽

Sodium bicarbonate treatment for QRS widening in bupropion overdoses.
PubMed 文献 · Clin Toxicol (Phila) · 2023-06-15
一句话结论回顾性队列显示碳酸氢钠未显著缩短安非他酮过量患者的QRS时限(中位变化-2.0毫秒,P=0.42)。

该回顾性队列纳入2010年1月至2022年6月10家医院的安非他酮过量患者,要求有碳酸氢钠给药记录且用药前心电图QRS>100毫秒,共13例进入最终分析。首次碳酸氢钠给药前中位剂量100毫当量,用药前后QRS中位变化-2.0毫秒,无统计学意义(P=0.42),且未发现QRS变化与碳酸氢钠剂量相关(P=0.9,R²=0.001)。无患者在首次给药后QRS<100毫秒。作者结论为碳酸氢钠未显著缩短QRS时限。

要点

  • 13例安非他酮过量伴QRS>100毫秒患者中,碳酸氢钠前后QRS中位变化-2.0毫秒,无统计学意义(P=0.42)。
  • 首次给药前中位碳酸氢钠剂量100毫当量,QRS变化与剂量无关联(P=0.9,R²=0.001)。
  • 无患者在首次碳酸氢钠给药后QRS降至<100毫秒。
  • 6例出现癫痫发作,1例出现室性心动过速,4例使用血管升压药。
  • 用药后QTc、电解质、心率、血压变化极小,8例达到碱血症。

适用人群与场景

  • 2010年1月至2022年6月10家医院收治的安非他酮过量患者,需有碳酸氢钠给药记录且用药前心电图QRS时限>100毫秒。
  • 排除无治疗前后4小时内电图者,以及基线(过量前)QRS已增宽且较基线增宽<10毫秒者。

诊断标准与关键阈值

  • 纳入标准:有碳酸氢钠给药记录,用药前心电图QRS时限>100毫秒。
  • 排除标准:无治疗前后4小时内电图;基线(过量前)QRS已增宽且较基线增宽<10毫秒。

红旗征与不能漏的情况

  • 6例出现癫痫发作。
  • 1例出现室性心动过速。
  • 4例需使用血管升压药。

研究设计与关键结果

  • 回顾性队列研究,10家医院,2010年1月至2022年6月,13例安非他酮过量患者进入最终分析;中位年龄32岁,54%为男性。
  • 首次碳酸氢钠给药前中位QRS 116毫秒、中位QTc 495毫秒;首次给药前中位碳酸氢钠剂量100毫当量。
  • 主要终点:碳酸氢钠前后QRS中位变化-2.0毫秒,无统计学意义(P=0.42)。
  • QRS变化与碳酸氢钠剂量无关联(P=0.9,R²=0.001)。
  • 无患者在首次碳酸氢钠给药后QRS<100毫秒。
  • QTc、电解质、心率、血压变化极小;8例用药后达到碱血症。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:样本量小(13例);作者称「small retrospective cohort」。

对床旁实践的改变

  • 作者结论:在此小样本回顾性队列中,碳酸氢钠未显著缩短安非他酮过量患者的QRS时限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Bupropion cardiotoxicity widens QRS complexes by inhibiting cardiac gap junctions. Sodium bicarbonate is the standard treatment for QRS widening from sodium channel blockade, but its effect on QRS widening in bupropion cardiotoxicity is not well-studied.

METHODS: This is a retrospective cohort study of bupropion overdoses from 10 hospitals between January 2010 and June 2022. Patients with documented administration of sodium bicarbonate and QRS duration > 100 milliseconds on pre-bicarbonate electrocardiogram were included. Patients with no electrocardiogram within four hours of treatment or with baseline pre-overdose wide QRS and < 10 milliseconds widening from baseline were excluded. The primary outcome was a change in QRS duration between the pre-bicarbonate electrocardiogram and the first electrocardiogram after initial bicarbonate administration. Secondary outcomes included prevalence of post-bicarbonate QRS < 100 milliseconds, change in electrocardiogram intervals after total bicarbonate administration, and change in metabolic parameters and hemodynamics. Wilcoxon signed-rank testing was performed on the primary outcome. Linear regression modeling was performed to test for an association between change in QRS and bicarbonate dosing.

RESULTS: Thirteen patients were included for final analysis. The median age was 32 years, and 54% were male. Six patients developed seizures; one developed ventricular tachycardia, and four received vasopressors. The median QRS and QTc pre-bicarbonate were 116 and 495 milliseconds, respectively. The median change in QRS duration was -2.0 milliseconds, which was not statistically significant (P = 0.42). The median bicarbonate dose administered before the first post-bicarbonate electrocardiogram was 100 milliequivalents. We did not identify an association between QRS change and bicarbonate dosing (P = 0.9, R-squared = 0.001). No patient had a QRS duration < 100 milliseconds after the initial bicarbonate dose. There was minimal change in QTc, electrolytes, heart rate, or blood pressure; alkalemia post-bicarbonate was achieved in eight patients.

CONCLUSION: Sodium bicarbonate did not significantly decrease QRS duration in this small retrospective cohort of bupropion overdoses.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Simpson M, Johnson L, Goldfine C, et al. Sodium bicarbonate treatment for QRS widening in bupropion overdoses. Clin Toxicol (Phila). 2023. PMID: 37318051. doi:10.1080/15563650.2023.2218029

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。